Cardiac Implant Market is expected to witness a CAGR of 11.6% during the forecast period | Medtronic Plc. BIOTRONIK, Inc., Boston Scientific Corporation, Abbott Laboratories, Vitatron Holding B.V.

Cardiac implants are devices that are used to detect abnormal heartbeats in patients who have cardiac rhythm problems. Problems in the heart’s electrical system, which tells the heart to contract and circulate blood to the entire body, cause these anomalies. Some of the cardiac implant devices are cardiac resynchronization therapy, implantable cardioverter defibrillators (ICDs), implantable hemodynamic monitors, implanted heart rhythm monitoring (sometimes referred to as loop recorders), and pacemakers. Such implants can be treated with acute myocardial infarction, arrhythmias, and myocardial ischemia.

The PDF for the study can be requested using the following link: https://www.coherentmarketinsights.com/insight/request-pdf/1176

As the population and demographics change, the incidence of heart disease is expected to rise, resulting in rising demands for cardiac implants during the forecast period. For instance, according to the American College of Cardiology, cardiovascular diseases are the biggest cause of death in the U.S., accounting for around 800,000 death cases in 2017.

In 2018, the global cardiac implants market was worth US$ 34,783.4 Mn, and it is expected to register at a CAGR of 11.6 % over the forecast period of 2019 to 2026.

Rising regulatory approvals for cardiac implants is expected to propel the global cardiac implants market growth over the forecast period

In individuals at risk of cardiac disease, most hospitals and healthcare organizations recommend cardiovascular implants to offer long-term artificial regulation of the patient’s heartbeat. The global cardiac implants market is expected to rise during the forecast period, owing to a rising number of regulatory approvals for new and sophisticated cardiac implant devices. For instance, Abbott received approval from the U.S. Food and Drug Administration (FDA) in February 2017 for the Assurity MRI pacemaker, it is the world’s smallest and longest-lasting, compatible with MRI, wireless pacemaker. If necessary, patients with an Assurity MRI pacemaker could have whole-body MRI scans.

Furthermore, the global rise in the prevalence of cardiovascular diseases is expected to propel the global cardiac implants market growth during the forecast period. According to the World Health Organization (WHO), cardiovascular diseases caused around 17.7 million death cases in 2015, with 6.7 million deaths owing to stroke and 7.4 million deaths owing to coronary heart disease.

Infections linked to implanted pacemakers in the cardiac patients are expected to deter patients from adopting these devices thus, decreasing the necessity of cardiac implants. According to Medtronic Plc. – possible risks related to implantable cardioverter defibrillators implants are sensitivity to the device material, surgical site infections, inability to provide therapy when required, and getting additional therapy even when not necessary. Furthermore, after getting ICD therapy, the patient will be restricted from magnetic and electromagnetic radiation.

Apply Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/1176

The global cardiac implants market is segmented into the Middle East, Latin America, Africa, Asia Pacific, North America, and Europe.

Due to growing demand for pacemakers, North America is expected to account for the largest share in the global cardiac implants market. According to the American Heart Association (AHA), around 92.1 million individuals in the U.S. suffer from cardiovascular disease or stroke-related complications in 2017. According to the AHA analysis, the direct and indirect costs of stroke and cardiovascular diseases amount to US$ 316 billion, which includes health expenses and lost production.

Rising consumer demand for technologically improved devices for cardiac rhythm control, as well as rising healthcare problems about atrial fibrillation-related stroke prevention, are the factors expected to fuel the Asia Pacific cardiac implants market growth over the forecast period

In 2017, according to the Japanese Heart Rhythm Society, by 2050 the Asian people with atrial fibrillation (AF) are expected to grow to 72 million, with 2.9 million of those suffering from AF-related strokes.

Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1176

Due to a rising approval of cardiac implants for diverse purposes by European Drug Regulatory Authorities, Europe is expected to expand at a substantial rate. for instance, EBR Systems received CE marking for their WiSE leadless pacemaker in 2015. This device is designed to help the left ventricle function better. Furthermore, Medtronic Plc. received CE marking in February 2017 for a series of quadripolar cardiac resynchronization therapy pacemakers (CRT-Ps) that help patients to undergo MRI scans.

Major players contributing to the global cardiac implants market are Lepu Medical Technology Co Ltd., Boston Scientific Corp., Qinming Medical, Shree Pacetronix Ltd., Vitatron Holding B.V., Cordis Inc., BIOTRONIK, Inc., MEDICO S.p.A., Abbott Laboratories, and Medtronic Plc.

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Overview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Device Type
     • Market Snippet, By Application
     • Market Snippet, By End User
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Market Trends
   • Key Developments
   • Technology Advancements
   • Historical Overview
   • Mergers and Acquisitions
   • Regulatory Scenario
   • PORTER’S Five Forces
   • PEST Analysis
4. Global Cardiac Implant Market, By Device Types Type 2016 – 2026, (US$ Million)
   • Introduction
     • Market Share Analysis, 2018 and 2026 (%)
     • Y-o-Y Growth Analysis, 2017 – 2026
     • Segment Trends
   • Pacemaker Devices
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Cardiac Resynchronization Therapy Devices
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Implantable Hemodynamic Monitoring Devices
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Implanted Heart Rhythm Monitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Coronary Stents
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Implantable Cardioverter Defibrillator
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Heart Valve
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
5. Global Cardiac Implant Market, By Application, 2016 – 2026, (US$ Million)
   • Introduction
     • Market Share Analysis, 2018 and 2026 (%)
     • Y-o-Y Growth Analysis, 2017 – 2026
     • Segment Trends
   • Arrhythmias
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Myocardial Ischemia
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Acute Myocardial Infraction
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Congestive Heart Failure
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
6. Global Cardiac Implant Market, By End User, 2016 – 2026, (US$ Million)
   • Introduction
     • Market Share Analysis, 2018 and 2026 (%)
     • Y-o-Y Growth Analysis, 2017 – 2026
     • Segment Trends
   • Hospitals
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Specialty Clinics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Ambulatory Surgical Centers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
7. Global Cardiac Implant Market, By Region, 2016 – 2026, (US$ Million)
   • Introduction
     • Market Share Analysis, By Region, 2018 and 2026 (%)
     • Y-o-Y Growth Analysis, By Region, 2017 – 2026
     • Regional Trends
   • North America
     • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
       • China
       • Japan
       • India
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Africa
     • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
       • North Africa
       • Central Africa
       • South Africa
   • Middle East
     • Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
       • GCC Countries
       • Israel
       • Rest of Middle East

Press Release: https://www.coherentmarketinsights.com/press-release/cardiac-implant-market-to-surpass-us-837-billion-by-2026-1713